Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS

v3.5.0.2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2016
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
9.  RELATED PARTY TRANSACTIONS
 
The Company’s former Chief Scientific Officer and principal founder of Cellectar, resigned after the end of the second quarter of 2016, continues to be a shareholder of the Company, and is a faculty member at our research partner the University of Wisconsin-Madison (“UW”). During the six months ended June 30, 2016, the Company incurred approximately $159,000 in expenses from UW for costs associated with clinical trial agreements. The Company had accrued liabilities to UW of approximately $84,000 as of June 30, 2016.